WBA
57
-6
PPG
58
-2
ORCL
50
-2
GRMN
56
-3
SRE
38
-9
UPS
50
-5
CVX
28
-3
WYNN
26
3
AMP
47
-3
R
63
-3
NVDA
47
-3
APH
67
-4
NWSA
73
-3
NEM
42
-2
VRTX
58
-2
ISRG
71
2
NWL
54
-6
SO
48
4
PGR
55
-3
WHR
65
-5
WBA
57
-6
PPG
58
-2
ORCL
50
-2
GRMN
56
-3
SRE
38
-9
UPS
50
-5
CVX
28
-3
WYNN
26
3
AMP
47
-3
R
63
-3
NVDA
47
-3
APH
67
-4
NWSA
73
-3
NEM
42
-2
VRTX
58
-2
ISRG
71
2
NWL
54
-6
SO
48
4
PGR
55
-3
WHR
65
-5
Financhill
Back

Monopar Therapeutics Vs. Perspective Therapeutics Industry Stock Comparison

Buy
75

MNPR
Monopar Therapeutics

Last Price:
30.10
Seasonality Move:
35.55%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.07
Seasonality Move:
27.93%
Buy
75
Monopar Therapeutics (MNPR) is a Buy

Is Monopar Therapeutics a Buy, Sell or Hold?

  • The current Monopar Therapeutics [MNPR] share price is $30.68. The Score for MNPR is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • MNPR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.07. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MNPR Stock Price Chart

What is Monopar Therapeutics's stock price today?

  • The Monopar Therapeutics share price today is $30.68
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.07
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.92 Buy
Relative Strength Index (14 RSI): 76.63 Buy
Chaikin Money Flow: 62338 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.5 - 24.7) Buy
Bollinger Bands (100): (1.59 - 18.41) Buy

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.53 Sell
Relative Strength Index (14 RSI): 20.31 Sell
Chaikin Money Flow: -1528174 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.76 - 7.16) Sell
Bollinger Bands (100): (7.26 - 15.12) Sell

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.74 Buy
20-day SMA: 22.43 Buy
50-day SMA: 16.57 Buy
200-day SMA: 6.79 Buy
8-day EMA: 25.62 Buy
20-day EMA: 22.75 Buy
50-day EMA: 17.67 Buy
200-day EMA: 9.07 Buy

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.52 Sell
20-day SMA: 3.98 Sell
50-day SMA: 8.6 Sell
200-day SMA: 12.31 Sell
8-day EMA: 3.52 Sell
20-day EMA: 4.66 Sell
50-day EMA: 7.49 Sell
200-day EMA: 10.23 Sell

Monopar Therapeutics Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.58 per share, and a decrease next year of $0.91 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.

Monopar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):